We're attending PDA this year! 📍Phoenix, Arizona 📅 October 22nd - 23rd Our lovely US team will be there to present "Integrating the Voice of the Patient (VoP) in Drug Delivery Device Strategy and Development: A Path Toward Patient-Centric Innovation" by Mark T. Comment below if we'll be seeing you there 👇 #Tradeshow #WePutPatientsFirst #PDA
NEMERA
Fabrication d’équipements médicaux
Lyon, Auvergne-Rhône-Alpes 25 480 abonnés
We put patients first.
À propos
Nemera is one of the world leaders in the design, development and manufacturing of drug delivery solutions. Its expertise covers all five modes of delivery: ● ophthalmic (preservative free droppers), ● nasal, buccal, auricular (sprays pumps, etc.), ● pulmonary (inhalers), ● dermal and transdermal (dispensers), ● parenteral (injectors, pens, safety devices). Nemera provides solutions for the pharmaceutical industry, including standard innovative products, development of custom devices and contract manufacturing. For more information, please visit http://www.nemera.net If you want to contact us: [email protected]
- Site web
-
https://www.nemera.net/
Lien externe pour NEMERA
- Secteur
- Fabrication d’équipements médicaux
- Taille de l’entreprise
- 1 001-5 000 employés
- Siège social
- Lyon, Auvergne-Rhône-Alpes
- Type
- Société civile/Société commerciale/Autres types de sociétés
- Fondée en
- 2015
- Domaines
- Drug delivery devices, Ophthalmic, Preservative-free, Multidose eye droppers, Inhalation, Nasal, Ear Nose Throat, Nasal spray pumps, PMDI, DPI, Inhalers, Dermal, Transdermal, Airless dispensers, Parenteral, Injectable, Autoinjectors, Insulin pen, Passive safety devices, Implanters, Glaucoma, Dry eye, Allergic rhinitis, Eczema, Psoriasis, Diabetes, Asthma, COPD, Design, Industrialization et Large scale manufacturing
Lieux
-
Principal
63, Avenue Tony Garnier
69007 Lyon, Auvergne-Rhône-Alpes, FR
-
17, Route d’Eu
76470 Le Tréport, FR
-
Rheinwaldstrasse 10
79395 Neuenburg am Rhein, DE
-
600 Deerfield Parkway
60089 Buffalo Grove, Illinois, US
Employés chez NEMERA
Nouvelles
-
In ONdrugDelivery’s latest wearables edition Nemera’s experts Cécile Gross and Mark T. discuss how Nemera‘s on-body injector platform – Symbioze® – has been developed by lessons learned from the history of injection devices and the company’s extensive experience in the parenteral route. Do give the article a read and understand how this large-volume on-body injector platform fosters patients' injection experience. Find the article's link in comment. #weputpatientsfirst #onbodyinjector #wearables #parenteral
-
Here's a sneak peek at what products we'll be showing at CPhI this year! 👀☝️ #Tradeshow #WePutPatientsFirst #CPhI #productoffering
-
Did you know we're attending CPhI soon? It's the biggest event of the year! 📍Milan, Italy 📆 8th - 10th October Our full team will be there to present our range of products and services. Let us know if you'll be attending! 👇 #Tradeshow #WePutPatientsFirst #CPhI
-
As we pursue our ESG journey, we’re pleased to share a bit more about our campaign 'The Mark You Make'. A lot of times, our warehouse employees don't have a clear vision of the whole drug delivery device value chain and the ultimate product that goes into the hands of patients. 'The Mark You Make' campaign helped our employees to get a better understanding of the positive impact they make for patients through their day-to-day activities. By raising awareness on how our products are used by patients, we have seen an increase in the pride people have in their work. Know more about our ESG initiatives in our 2023 ESG report: https://lnkd.in/e9gfu9JX #weputpatientsfirst #ourpeople #ESG
-
Here's what our Director of Engineering, Guillaume Moins, has to say about his time working at Nemera. Do read until the end to find out the secret of what makes the Nemera Engineering team make a true difference! ☝️ #weputpatientsfirst #engineering #customersatisfaction #industry4.0 😊
-
On the occasion of International Overdose Awareness day, August 31, we believe we can all contribute to preventing overdoses of our loved ones as well as raise awareness around the cause. We’ve developed and manufacture UniSpray, a single-metered dose for rescue & crisis intervention with the aim of reducing fatal consequences for individuals. To know more about this initiative of IOAD: International Overdose Awareness Day: 31 August (overdoseday.com) To know more about our device Unispray: https://lnkd.in/dWjihuKw #weputpatientsfirst #overdoseprevention #IOAD
-
We released our 2023 ESG report back in June! 📆 Did you miss it? Check it out to discover our sustainability priorities and objectives 🌱
📢 We’re pleased to reveal our 2023 ESG report “Our Commitment to Sustainability” on the momentous occasion of World Environment Day. ✔ This report provides a snapshot of where we stand today on sustainability, our strategic priorities and objectives, material topics and the progress we have made over the years. 🗺 We welcome everyone reading this report to engage further with us on sustainability, so that we can effectively scale the positive impact of our work and, together, seek to leave a healthier planet for future generations to come. Read the entire report: https://lnkd.in/e9gfu9JX #worldenvironmentday #environment #social #governance #SDGs #GRIs #weputpatientsfirst
-
Nemera is 10 years old! 🎂 Over the last 10 years, many things have changed here at Nemera, but one thing has always stayed the same, our unwavering commitment to putting patients first. Watch this video to find out more about our journey, what we've achieved with our passion, dedication and continued commitment as well as what the future holds 👇 🧡 #weputpatientsfirst #10yearsofnemera #anniversary #globalcompany
-
We're very proud of this one! 🧡🌱
At Nemera, we have been taking many actions to improve our impact on the environment 🌱 Last year, we were happy to announce that our carbon emission targets were validated by the SBTi ✅ In addition and to ensure the integrity of our carbon emission calculation, we conducted our first carbon emissions audit. These actions have contributed a lot to the increase in our score.